SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CollaGenex (CGPI) FDA PENDING
CGPI 0.00010000.0%Jul 21 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom D who wrote (18)10/20/1997 1:23:00 AM
From: Vector1   of 142
 
<<I can't figure out what is making the FDA unhappy.>>

Tetracycline as you know is an antibiotic. Even though the dosage in Periostat is very small-in fact insufficient to kill bacteria-- the FDA is very concerned about bacterial resistence. In addition the FDA does not view this as a treatment for a life threatening disease and therefor can be counted on to be sticklers.
V1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext